17 Oct 2017

NIH launches $215M public-private partnership to support Cancer Moonshot

The National Institutes of Health has launched a five-year, $215 million public-private partnership with 11 biopharmaceutical vendors to accelerate development of new immunotherapy treatments in support of the Cancer Moonshot initiative. The Partnership for Accelerating Cancer Therapies (PACT), which will be managed by the Foundation for the National Institutes of

13 Oct 2017

NIH launches $215m partnership for cancer immunotherapy strategies

The NIH and 11 leading biopharmaceutical companies have launched the Partnership for Accelerating Cancer Therapies (PACT), totalling $215m as part of the Cancer Moonshot…. The National Institutes of Health (NIH) and 11 leading biopharmaceutical companies today launched the Partnership for Accelerating Cancer Therapies (PACT), a five-year public-private research collaboration totalling

18 Sep 2017

Government hospitals makeover under Public Private Partnership mode

Health Minister Kamineni Srinivas said that the state government is contemplating to hand over eight government hospitals to corporate hospitals if they come forward. Speaking to the media here on Saturday, Kamineni stated the government wants to develop infrastructure and improve medical services at district headquarters hospitals under the Public

11 Sep 2017

Public-private partnership gives lifeline to diabetes patients

Living with a health condition that constantly threatens your life for more than 36 years is no walk in the park. For Jane Muthoni, 44, tonsillitis at the age of eight was just another normal childhood ailment. She never imagined it could be an early sign of a condition she

31 Aug 2017

Philips India to increase PPP healthcare centres

Philips India on Tuesday said it is set to increase to 36 the number of public-private partnership (PPP) healthcare centres across the states of Haryana and Jharkhand by early 2019. According to the company, at present there were 10 operational PPP centres across Haryana and seven in Jharkhand. There were

01 Aug 2017

Antabio Wins $2.8 Million P3 Grant to Keep Developing Drug-Resistant Infection Therapy

A U.S. government-backed initiative against drug-resistant bacteria has awarded Antabio $2.8 million to continue developing treatments for Pseudomonas, the most common infection in cystic fibrosis (CF). The grant came from a public-private partnership known as CARB-X, which stands for Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator. CARB-X, formed in July 2016,

27 Jul 2017

A*STAR enters into PPP to develop personalised cancer treatment

Four cancers were specially chosen as they are prevalent in Singapore and across Southeast Asia and have no biomarker-guided therapy. The Agency for Science, Technology and Research (A*STAR),  Singapore’s lead public sector agency for economic oriented research, entered into a partnership with a Singapore-based start-up, Invitrocue, on July 25. Invitrocue

24 Jul 2017

Niti Aayog’s healthcare PPP needs clarity: Hospitals

Niti Aayog’s proposal to rope in private healthcare providers to diagnose and treat certain non-communicable diseases in district government hospitals has received mixed reactions. While most private hospitals see the plan as a comprehensive attempt at constructing a successful public-private partnership (PPP) model in healthcare, some are wary of engaging

20 Jul 2017

Government may partner with private sector to provide healthcare through PPP

With the World Bank as technical partner, Niti Aayog and the health ministry have proposed a public-private partnership model to provide diagnosis and treatment for three non-communicable diseases in three fields — cardiac sciences, oncology and pulmonary sciences — in non-metro cities. The proposal envisages each state identifying five to

Vials and Syringe
14 Jul 2017

Jamaica Cancer Drug Aims For Yearly US$250m Haul

Scientist and businessman Dr Henry Lowe is predicting annual sales of US$250 million, the equivalent of around $32 billion, from Cresorol, an anti-cancer drug made from marijuana. The product, which targets acute myeloid leukemia (AML) has been designated an ‘orphan drug’ by the US Food and Drug Administration, the FDA,